![](/images/graphics-bg.png)
Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care
Joint Authors
Kato, Harubumi
Kihara, Makoto
Marko-Varga, György
Kato, Yasufumi
Nishimura, Toshihide
Ikeda, Norihiko
Nomura, Masaharu
Source
International Journal of Proteomics
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-05-22
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Natural & Life Sciences (Multidisciplinary)
Biology
Abstract EN
An overview on targeted personalized medicine is given describing the developments in Japan of lung cancer patients.
These new targeted therapies with novel personalized medicine drugs require new implementations, in order to follow and monitor drug efficacy and outcome.
Examples from IRESSA (Gefitinib) and TARCEVA (Erlotinib) treatments used in medication of lung cancer patients are presented.
Lung cancer is one of the most common causes of cancer mortality in the world.
The importance of both the quantification of disease progression, where diagnostic-related biomarkers are being implemented, in addition to the actual measurement of disease-specific mechanisms relating to pathway signalling activation of disease-progressive protein targets is summarised.
An outline is also presented, describing changes and adaptations in Japan, meeting the rising costs and challenges.
Today, urgent implementation of programs to address these needs has led to a rebuilding of the entire approach of medical evaluation and clinical care.
American Psychological Association (APA)
Nishimura, Toshihide& Kato, Harubumi& Ikeda, Norihiko& Kihara, Makoto& Nomura, Masaharu& Kato, Yasufumi…[et al.]. 2012. Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care. International Journal of Proteomics،Vol. 2012, no. 2012, pp.1-10.
https://search.emarefa.net/detail/BIM-508360
Modern Language Association (MLA)
Nishimura, Toshihide…[et al.]. Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care. International Journal of Proteomics No. 2012 (2012), pp.1-10.
https://search.emarefa.net/detail/BIM-508360
American Medical Association (AMA)
Nishimura, Toshihide& Kato, Harubumi& Ikeda, Norihiko& Kihara, Makoto& Nomura, Masaharu& Kato, Yasufumi…[et al.]. Cancer Phenotype Diagnosis and Drug Efficacy within Japanese Health Care. International Journal of Proteomics. 2012. Vol. 2012, no. 2012, pp.1-10.
https://search.emarefa.net/detail/BIM-508360
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-508360